Founded as a not-for-profit
Committed to foreskin regeneration
Supporters In Over 80 Countries Worldwide

Scroll to See More About Us


Our Foundation

Foregen is a registered and tax exempt 501(c)(3) non-profit organization founded to research and implement regenerative medical therapies for circumcised men. Thanks to an initial cohort of contributing donors, Foregen was created in 2010 with the goal of finding existing institutions to conduct research. In time, we found that the only way to accomplish our goals would be to establish our own scientific team and conduct the necessary research ourselves. After searching carefully for the right people, our scientific team was created and initial research started in 2014. Foregen now operates in both the United States and the European Union. Its head office is in Rome, Italy, where it is a registered charity (Reg. No. 6482, Serie 1T, 2010) and maintains domicile in the United States under section 501(c)(3) of the Internal Revenue Code. It is headed by a board of directors with volunteers and donors from over 80 countries across 6 continents.

Our Mission

Foregen’s goal is to heal the physical detriment that that is inherent to circumcision, including the functional and sensory losses to the penis when circumcised, as well as the potential for psychological damage for those on whom such surgery was performed. Fortunately, regenerative medical techniques offer great potential to regrow human tissue, especially dermal tissue, lost in prior trauma.

However, those techniques have not yet been applied to those who have been circumcised and no longer wish to be. After dismissing many unsatisfactory proposals from research institutions, we decided to conduct our own research and human clinical trials. With the help of dedicated scientists, we will apply known regenerative techniques to the foreskin in order to restore normal penile function and sensitivity.

Foregen is not an activist organization, and we have no legislative or political agenda; Foregen is a pioneering research organization dedicated to creating options for circumcised men. Foregen, although unique, is a great example of an organization that regenerative medicine was made for, as it applies to over one billion people - circumcised males and their partners! Since Foregen’s foundation, countless men have expressed great delight that an organization such as this finally exists, something for which they have been searching for years.

Our People

Foregen is led by the Board of Directors with help from its team of dedicated officers, scientists, and staff. Vincenzo Aiello heads the board as President, and is assisted by a Vice-President and an Advisory Board. More details on our team can be found below.

Vincenzo Aiello
World-renowned for restoring ancient Roman mosaics and creating new ones, contemporary artist Vincenzo Aiello founded Foregen in 2010– the first company of its kind that promotes foreskin regeneration with stem cells. Two years later, he extended Foregen’s 501(c)(3) status to the US. As a visionary man with extremely high standards, it took Enzo four years to find the right scientists for the job. Now that he has enlisted the right people, Enzo is confident that Foregen can achieve foreskin regeneration.
Vice President
Carlo Alberto Cirioni

A philosopher and anthropologist, Carlo Alberto Cirioni is a religious scholar and interpreter of ancient Biblical texts. Carlo is a longtime friend of Enzo's and as the vice president, he helps lead the creative direction of Foregen and is a visionary in his own right. Carlo also acts as Foregen’s Chief Financial Officer.

Chief Science Officer
Eric J. Cunningham

Eric J. Cunningham is Foregen’s Chief Science Officer. He holds a Bachelor’s Degree in Biomedical Engineering, with a specialization in Cell & Tissue Engineering, from Illinois Institute of Technology’s Armour College of Engineering. He is currently completing a Master’s Degree in Chemical Engineering at Illinois Institute of Technology.

He has experience in a variety of areas in Biomedical Engineering, from the development of imaging phantoms for use in Magnetic Resonance Imaging (MRI) and Magnetic Resonance Elastography (MRE) devices, to cardiac tissue regeneration and polymeric biomaterials engineering.
Chief Operations Officer
Tyler J. Drozd

Tyler is a driven advocate for genital integrity and pursuing the goal of giving every man back the choice of a whole body. He has considerable international experience, working with people from a variety of countries. After graduating from North Central College with a degree in World Languages - Spanish, German and Chinese, he became a Fulbright Scholar to Germany, where he is currently in his second year.

He wants to continue both his study of language as well as doing anything he can to support Foregen. When his time isn’t occupied with those goals, he can be found working on his art, the other passion in his life.  
Senior Director
Matthew Serody
Communications Specialist
Corey Milani
Communications Specialist
Jordan Arel
Information Technology Assistant
Mark Nasr
Business Networking Specialist
Robert Pitts
Technical Director
Elena Bondioli, Ph.D.
Dr. Bondioli is Foregen’s chief molecular biologist responsible for overseeing the success of all of Foregen’s lab and preclinical work. Dr. Bondioli has more than ten years of experience in decellularizing tissues to extract their extracellular molds and then regenerating them for patients, which is the same fundamental scientific process that Foregen’s success depends on.

She has written numerous national and international patents and publications, and is currently the technical director responsible for overseeing the bioengineering and somatic tissue cell therapy department of Regional Cell Bank of Emilia Romagna, a ten-million dollar facility tasked with regenerating skin for burn victims.
Clinical Researcher
Valeria Purpura, Ph.D.  

Dr. Purpura was a senior diagnostic molecular biologist at Praximedica before becoming Dr. Bondioli’s head biotechnologist at the Regional Cell Bank of Emilia Romagna. She received her Ph.D. in experimental medicine in 2012, studying the molecular mechanisms involved in the modulation of fibroblast and keratinocyte growth factors. Dr. Purpura is highly experienced in PCR technologies, histomorphological testing, and validating the safety and efficacy of therapeutic biomaterials for use on patients.

Legal Adviser
Peter Adler, J.D., M.A.
Peter W. Adler is Foregen's Legal Adviser. He received his Bachelor's Degree in Philosophy from Dartmouth College (magna cum laude, Phi Beta Kappa) in 1973, a Masters Degree in Philosophy from Cambridge University (Honours) in 1975, and a J.D. from University of Virginia School of Law in 1983, where he was Editor of the Virginia Law Review and Virginia Journal of International Law.

Previously, Mr. Adler was the Assistant Vice President of the European Division for J.P. Morgan Chase, Attorney of corporate law in charge of business litigation at Myerow, Resnick, Poirier & Adler, and successfully founded and operated multiple e-commerce startups. He is currently a professor of International Law, International Business Law, Business Law, and International Business at the University of Massachusetts in Lowell, Massachusetts. As a part of a study abroad program, Mr. Adler teaches courses in Copenhagen, Denmark each summer.

Research Adviser
Ken Drabik, M.S.
Mr. Drabik is a Senior Research Technologist at the University of Chicago. He has campaigned for human rights around the world and his expertise led him to assist in the making of the movie Cut, which discusses the issue of male circumcision.

Robert Van Howe, M.D.
Dr. Robert Van Howe is a pediatrician who is currently serving as medical director for the public health departments serving nine counties in the Upper Peninsula of Michigan. He completed his B.A. in Chemistry and Philosophy at Saint Olaf College in Minnesota, earned his Doctor of Medicine degree from Loyola University Stritch School of Medicine in Maywood, Illinois, and completed his pediatrics residency at the Children's Hospital of Wisconsin in Milwaukee. Dr. Van Howe also holds an M.S. in Clinical Research Design and Statistical Analysis from the University of Michigan School of Public Health.

He was a clinical professor in the Department of Pediatrics and Human Development at the Michigan State University College of Human Medicine before becoming a professor and founding Chief of Pediatrics at the Central Michigan University College of Medicine. For over 20 years he has published several works on the topic of genital integrity and circumcision.
Research Adviser
William Musa, M.S.

William Graduated from Thomas Jefferson University with his MS in Biotechnology.  He has experience in a variety of scientific applications, including the use of animal husbandry for laboratory settings as well as experience with human tissue.  He completed his thesis in a regenerative medicine lab investigating protein pathways related to tissue growth after non-thermal plasma treatments.  

William continued to work with medical diagnostics after graduating, working with tissue histology and PCR based diagnostics.  William has an active interest in advancing the ethics and human rights for those effected by circumcision.
Communications Adviser
Elena Tartaglione Steiner, Ph.D.

Having completed her PhD at Arizona State University’s Hugh Downs School of Human Communication, Elena contributes her background in intercultural, strategic, and organizational communication to Foregen objectives. She has extensive experience as a research assistant at ASU’s Center for Strategic Communication, and contributed media, narrative framing, cultural analysis to public sector initiatives in the United States. Elena was faculty in communication for eight years at Regis University where she also completed her M.A. in International Communication.

She was managing partner of Global Perspectives Consulting, offering consultation and training in the areas of intercultural communication and competence across public, private, and non-profit sectors. She has lived, worked, or studied in over 20 countries and has working proficiency in German and limited working proficiency in French. Elena is currently researching and developing curricula with a multinational management and technology dual-education organization outside the United States.